pirfenidone has been researched along with Acute Respiratory Distress Syndrome in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Jiao, Y; Tan, Y; Tang, X; Wang, D; Yong, C; Zhang, R | 1 |
Al-Gareeb, AI; Al-Kuraishy, HM; Batiha, GE; Faidah, H; Saad, HM; Simal-Gandara, J | 1 |
Chang, C; Du, Y; Fang, X; Gao, Y; Li, H; Li, T; Mu, M; Qin, X; Qu, G; Wang, X; Wang, Y; Xu, G; Yu, S; Zhang, Z; Zhu, P | 1 |
Kang, S | 1 |
1 review(s) available for pirfenidone and Acute Respiratory Distress Syndrome
Article | Year |
---|---|
Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals.
Topics: Acute Lung Injury; COVID-19 Drug Treatment; Fibrosis; Goals; Humans; Pulmonary Fibrosis; Respiratory Distress Syndrome; SARS-CoV-2 | 2022 |
3 other study(ies) available for pirfenidone and Acute Respiratory Distress Syndrome
Article | Year |
---|---|
Pirfenidone ameliorates early pulmonary fibrosis in LPS-induced acute respiratory distress syndrome by inhibiting endothelial-to-mesenchymal transition via the Hedgehog signaling pathway.
Topics: Animals; Hedgehog Proteins; Lipopolysaccharides; Pulmonary Fibrosis; Pyridones; Respiratory Distress Syndrome; Signal Transduction | 2022 |
Pirfenidone alleviates lipopolysaccharide-induced lung injury by accentuating BAP31 regulation of ER stress and mitochondrial injury.
Topics: Acute Lung Injury; Alveolar Epithelial Cells; Animals; Apoptosis; Cells, Cultured; Disease Models, Animal; Endoplasmic Reticulum Stress; Gene Knockdown Techniques; Humans; Lipopolysaccharides; Male; Membrane Proteins; Mice; Mitochondria; Primary Cell Culture; Pulmonary Alveoli; Pyridones; Respiratory Distress Syndrome | 2020 |
2014 American Thoracic Society International Conference.
Topics: Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Asthma; Congresses as Topic; Eosinophilia; Expectorants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Idiopathic Pulmonary Fibrosis; Indoles; Lung Neoplasms; Protein Kinase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyridones; Respiratory Distress Syndrome | 2014 |